A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data
about
Application of radiation technology in vaccines developmentTuberculosis vaccine types and timingsEffects of MVA85A vaccine on tuberculosis challenge in animals: systematic reviewAccelerating tuberculosis vaccine trials with diagnostic and prognostic biomarkers.Using Data from Macaques To Predict Gamma Interferon Responses after Mycobacterium bovis BCG Vaccination in Humans: a Proof-of-Concept Study of Immunostimulation/Immunodynamic Modeling Methods.Immune subdominant antigens as vaccine candidates against Mycobacterium tuberculosis.Immunology studies in non-human primate models of tuberculosisMolecular and biochemical characterization of recombinant guinea pig tumor necrosis factor-alphaThe Efficacy of the BCG Vaccine against Newly Emerging Clinical Strains of Mycobacterium tuberculosisUnderstanding immune protection against tuberculosis using RNA expression profilingA new tool for tuberculosis vaccine screening: Ex vivo Mycobacterial Growth Inhibition Assay indicates BCG-mediated protection in a murine model of tuberculosis.Immunogenicity and Protective Efficacy of the DAR-901 Booster Vaccine in a Murine Model of Tuberculosis.Tuberculosis vaccine development: Shifting focus amid increasing development challenges.Safety, immunogenicity, and efficacy of the candidate tuberculosis vaccine MVA85A in healthy adults infected with HIV-1: a randomised, placebo-controlled, phase 2 trial.Protection and Long-Lived Immunity Induced by the ID93/GLA-SE Vaccine Candidate against a Clinical Mycobacterium tuberculosis Isolate.The TB-specific CD4(+) T cell immune repertoire in both cynomolgus and rhesus macaques largely overlap with humans.Effect of bacillus Calmette-Guérin vaccination on CD4+Foxp3+ T cells during acquired immune response to Mycobacterium tuberculosis infectionNovel vaccine potential of Rv3131, a DosR regulon-encoded putative nitroreductase, against hyper-virulent Mycobacterium tuberculosis strain K.Large animal models for vaccine development and testing.Animal models in tuberculosis research - where is the beef?Mycobacterium tuberculosis virulence: insights and impact on vaccine development.Functionality of Intrinsic Disorder in Tumor Necrosis Factor-α and its Receptors.A review of clinical models for the evaluation of human TB vaccines.Towards new TB vaccines: What are the challenges?The long and winding road to inhaled TB therapy: not only the bug's fault.TB vaccine development: where are we and why is it so difficult?MTBVAC from discovery to clinical trials in tuberculosis-endemic countries.Induction of an Immune-Protective T-Cell Repertoire With Diverse Genetic Coverage by a Novel Viral-Vectored Tuberculosis Vaccine in Humans.Enhancement of Antituberculosis Immunity in a Humanized Model System by a Novel Virus-Vectored Respiratory Mucosal Vaccine.Intravital excitation increases detection sensitivity for pulmonary tuberculosis by whole-body imaging with β-lactamase reporter enzyme fluorescence.Rhesus macaques are more susceptible to progressive tuberculosis than cynomolgus macaques: A quantitative comparison.Effects of MVA85A vaccine on tuberculosis challenge in animals: systematic review.Development of a non-human primate BCG infection model for the evaluation of candidate tuberculosis vaccines.Mucosal Delivery of Fusion Proteins with Bacillus subtilis Spores Enhances Protection against Tuberculosis by Bacillus Calmette-Guérin.Progress and challenges in TB vaccine development.Comparison of immunogenicity and vaccine efficacy between heat-shock proteins, HSP70 and GrpE, in the DnaK operon of Mycobacterium tuberculosis
P2860
Q26798165-4FC462E2-E4F2-4DBB-B65F-932ADD8818DBQ26862762-FC305F0C-2D93-4B75-B1EC-2B00B73BE68DQ28088745-D9B9D49F-0F43-42ED-B303-0C5BE52DA7EBQ30403003-250A01EF-323F-4589-A83B-2352FBE4C0D6Q31154267-8733352B-E398-42A0-ACB7-546E738D2498Q34146613-17F41FEA-2A47-4F1D-8C8B-C447211723AFQ35116998-33084630-3A5D-4155-AAB4-5FDA81A7BED1Q35592437-240CF001-DFAC-4D79-8125-512D04EB8AF0Q35774458-E348640C-CC2C-4F24-AD88-0BDD24AED390Q36092310-51B9ED93-C93D-43B2-B865-D6846D022B26Q36103177-ED591FA8-4410-41B5-9743-146E5EB7170BQ36229621-93CDFEBF-9915-4EDD-B283-15E6D7DDF95AQ36256304-FBA132AF-529A-49B5-80D1-7000E7CF2AFDQ36287555-32350D78-5754-4794-A3D0-D68C9AA95BE4Q36555077-DABFE361-5C13-4ECB-B8E8-0C58EAD4A76EQ36636763-89A6C1C1-8AD2-41DF-BE9E-AF1BE342BE86Q36676017-3F72B620-2609-4CB0-AC3D-B7D6195AF19DQ37685973-250C6E55-DED7-4765-A9C4-1ADCF0402196Q38492768-BE471372-1E39-4504-B869-D5DAAB064233Q38527417-D2BE6C04-6BB3-4F66-82EC-073A7F3D7382Q38539493-625CDC8D-92C9-44A0-9154-2F822BFFD109Q38659937-B84F3DDD-76BE-45B6-9F02-4D8E3E83642EQ38711772-AD8C80A0-C4FA-43BC-8958-911FBB9F905FQ38767468-B7E7C87F-10FF-4730-AB98-3082135848B7Q38782463-65AB92F8-42B1-44DB-9AA7-99CEE72DCCEDQ39092983-CF370766-9D48-45B7-AF34-2E939ADB31B4Q39266421-792AAB24-980D-4836-BAD0-C8D9F77087B4Q39323110-31FC881F-7C6B-477C-9D5F-BBCF53994D1CQ40190981-9667A277-9CAE-45E5-9BD4-06B2125746F0Q40501853-6EB596FC-54EF-4FBA-BB5C-3106DE3E962DQ41994280-5D29F816-C2AB-473B-BC2D-66AC2D657811Q42791868-7D9A9DFB-FC99-406A-8D29-A6DBE198727BQ51742073-D982A0A6-1E3B-4270-858F-13EBB9C4BE62Q52338712-BEA11FD9-4E44-430D-A54A-9BFFF226B164Q52641498-7578700E-0B90-495B-B84C-95FBE4ADDF07Q58695834-0FA57439-69A0-4FDE-A2E3-E807BCC431C5
P2860
A review of preclinical animal models utilised for TB vaccine evaluation in the context of recent human efficacy data
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
A review of preclinical animal ...... of recent human efficacy data
@ast
A review of preclinical animal ...... of recent human efficacy data
@en
A review of preclinical animal ...... of recent human efficacy data
@nl
type
label
A review of preclinical animal ...... of recent human efficacy data
@ast
A review of preclinical animal ...... of recent human efficacy data
@en
A review of preclinical animal ...... of recent human efficacy data
@nl
prefLabel
A review of preclinical animal ...... of recent human efficacy data
@ast
A review of preclinical animal ...... of recent human efficacy data
@en
A review of preclinical animal ...... of recent human efficacy data
@nl
P2860
P921
P3181
P1433
P1476
A review of preclinical animal ...... of recent human efficacy data
@en
P2093
Ann Williams
Helen McShane
P2860
P304
P3181
P356
10.1016/J.TUBE.2013.11.003
P407
P5008
P577
2014-03-01T00:00:00Z